City Health Information
Volume 32 (2013) New York City Department of Health and Mental Hygiene No. 3; 11-18
 

IN THIS ISSUE

Influenza Prevention and Control, 2013-2014
  • Vaccinate everyone aged 6 months and older against influenza as early as possible.
  • Give inactivated vaccine to all pregnant women in any trimester.
  • Get your flu vaccination as soon as vaccine becomes available and ensure that your staff does the same.

 

PNEUMOCOCCAL DISEASE AND INFLUENZA

Pneumococcal disease is a serious complication of influenza that causes at least 4,000 deaths annually in the US (40). Despite efforts to increase vaccination coverage in older adults, pneumococcal polysaccharide vaccine (PPSV23) coverage rates in NYC adults aged 65 and older are still far below the Healthy People 2020 goal of 80%. Between 2008 and 2010, PPSV23 coverage of older NYC adults increased in whites (54% vs 61%) and Asians (40% vs 44%), but decreased in blacks (48% vs 42%) and Hispanics (41% vs 39%) (41). PPSV23 is recommended for all patients aged 65 and older, aged 2 and older with high-risk medical conditions, and aged 19 through 64 who smoke or have asthma (Resources—CDC Pneumococcal disease prevention) (42).

Pneumococcal conjugate vaccine (PCV13) is routinely recommended for all children through age 5. Coverage in NYC is approximately 84% (unpublished data), and providers should continue to ensure that their young patients are vaccinated, particularly those entering prekindergarten or day care. New York State requires pneumococcal conjugate vaccination in these children, if born on or after January 1, 2008 (Resources—NYS Immunization Schedule) (43).

People older than age 5 at high risk for invasive pneumococcal disease due to immunocompromising conditions, functional or anatomic asplenia (eg, sickle cell disease), cerebrospinal fluid leaks, or cochlear implants (44) are also recommended to receive PCV13 in addition to PPSV23. For information on dosing schedules in children 6 through 18 years, visit cdc.gov. For information on dosing regimens for PCV13 in adults 19 years and older, visit cdc.gov.

Continue to IMPROVING VACCINATION RATES on the next page >